An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer.

Vanderbilt researcher P. Brent Ferrell, MD, is leading one of five projects selected by the 2022 Novartis Institutes for BioMedical Research Global Scholars Program.

Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.

A multidisciplinary team led by Vanderbilt University Medical Center investigator Alexander Bick, MD, PhD, has been awarded a $2 million, four-year grant to study inflammation at the single-cell level in the rare disease RUNX1-FPD.

Mariana Byndloss, DVM, PhD, and William Wan, PhD, have been named 2022 Pew Scholars in the Biomedical Sciences and Alexander Bick, MD, PhD, was selected to join the 2022 class of Pew-Stewart Scholars for Cancer Research. 

Five Vanderbilt University Medical Center faculty members have received Young Physician-Scientist Awards from the American Society of Clinical Investigation (ASCI), an elite honor society of physician-scientists.

Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, has been selected as the first VUMC Discovery Scholar in Health and Medicine.